These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 8522846)
41. Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. Pasternak B; Hviid A JAMA; 2010 Aug; 304(8):859-66. PubMed ID: 20736469 [TBL] [Abstract][Full Text] [Related]
42. Sequential development of herpes zoster duplex unilateralis during oral famciclovir treatment. Goo B; Cho SB; Chung KY J Dermatol; 2005 Nov; 32(11):933-4. PubMed ID: 16361760 [No Abstract] [Full Text] [Related]
43. Postherpetic neuralgia: impact of famciclovir, age, rash severity, and acute pain in herpes zoster patients. Dworkin RH; Boon RJ; Griffin DR; Phung D J Infect Dis; 1998 Nov; 178 Suppl 1():S76-80. PubMed ID: 9852980 [TBL] [Abstract][Full Text] [Related]
45. Famciclovir. Discovery and development of a novel antiherpesvirus agent. Jarvest RL; Sutton D; Vere Hodge RA Pharm Biotechnol; 1998; 11():313-43. PubMed ID: 9760686 [No Abstract] [Full Text] [Related]
48. Cost effectiveness of newer antiviral agents for herpes zoster: is the evidence spotty? Smith KJ; Roberts MS J Infect Dis; 1998 Nov; 178 Suppl 1():S85-90. PubMed ID: 9852982 [TBL] [Abstract][Full Text] [Related]
49. Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections. Perry CM; Wagstaff AJ Drugs; 1995 Aug; 50(2):396-415. PubMed ID: 8521764 [TBL] [Abstract][Full Text] [Related]
50. The effects of famciclovir and epidural block in the treatment of herpes zoster. Ahn HJ; Lim HK; Lee YB; Hwang SM; Lee WS; Ahn SK; Choi EH J Dermatol; 2001 Apr; 28(4):208-16. PubMed ID: 11449672 [TBL] [Abstract][Full Text] [Related]
52. European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. Werner RN; Nikkels AF; Marinović B; Schäfer M; Czarnecka-Operacz M; Agius AM; Bata-Csörgő Z; Breuer J; Girolomoni G; Gross GE; Langan S; Lapid-Gortzak R; Lesser TH; Pleyer U; Sellner J; Verjans GM; Wutzler P; Dressler C; Erdmann R; Rosumeck S; Nast A J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):20-29. PubMed ID: 27579792 [TBL] [Abstract][Full Text] [Related]
56. Percutaneous electrical nerve stimulation: an alternative to antiviral drugs for acute herpes zoster. Ahmed HE; Craig WF; White PF; Ghoname ES; Hamza MA; Gajraj NM; Taylor SM Anesth Analg; 1998 Oct; 87(4):911-4. PubMed ID: 9768793 [No Abstract] [Full Text] [Related]
58. Translating statistics for use in the clinic. Atkins CD J Gen Intern Med; 1997 Oct; 12(10):626-8. PubMed ID: 9346459 [No Abstract] [Full Text] [Related]
59. Antiviral therapy of herpes simplex and varicella-zoster virus infections. Wutzler P Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639 [TBL] [Abstract][Full Text] [Related]
60. Treatment of herpes simplex & varicella zoster infection. Barrg C; Sheehan G Ir Med J; 1996; 89(4):132-4. PubMed ID: 8824033 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]